Literature DB >> 27448284

Venous thromboembolism after lower limb arthroplasty: is chemical prophylaxis still needed?

Karan Malhotra1, Jan L Marciniak2, Sandra J Bonczek2, Neil Hunt2.   

Abstract

BACKGROUND: Venous thromboembolism (VTE) is a significant complication of lower limb arthroplasty. The National Institute for Health and Care Excellence recommends routine use of chemical and mechanical prophylaxis to prevent VTE. Our high-volume, elective, arthroplasty unit adopted this guidance in 2008.
PURPOSE: We examined our incidence of VTE before and after introduction of chemical thromboprophylaxis to determine whether the incidence of VTE reduced.
METHODS: We retrospectively gathered data on 2 cohorts of patients-from January 2004 to August 2007 (Group 1) and January 2010 to December 2012 (Group 2). Patients in Group 1 received mechanical prophylaxis only (unless particularly high risk for VTE), and patients in Group 2 received mechanical and chemical prophylaxis. We recorded VTE occurring within 6 months of surgery. Patients in Group 1 receiving chemical prophylaxis were excluded.
RESULTS: Group 1 had 2320 cases of primary and revision lower limb arthroplasty, and Group 2 had 1430 cases. VTE occurred in 37 cases in Group 1 (1.6 %), and in 17 cases in Group 2 (1.2 %). This difference was not statistically significant (p = 0.26). In Group 1, 1 patient died within 6 months due to pulmonary embolism (0.04 %); there were no VTE-related deaths in Group 2 (0 %). This was also not statistically significant (p = 0.06).
CONCLUSIONS: Although our VTE rate reduced by 0.4 % and our VTE-related mortality reduced by 0.04 % after introduction of chemical thromboprophylaxis, these differences were not statistically significant. Chemical thromboprophylaxis may not be required in all patients undergoing arthroplasty providing appropriate mechanical prophylaxis is used.

Entities:  

Keywords:  Thromboprophylaxis; Total hip arthroplasty; Total knee arthroplasty; Venous thromboembolism

Mesh:

Substances:

Year:  2016        PMID: 27448284     DOI: 10.1007/s00590-016-1820-9

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  15 in total

1.  Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?

Authors:  R Yokote; M Matsubara; N Hirasawa; S Hagio; K Ishii; C Takata
Journal:  J Bone Joint Surg Br       Date:  2011-02

2.  Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study.

Authors:  C Howie; H Hughes; A C Watts
Journal:  J Bone Joint Surg Br       Date:  2005-12

Review 3.  Fast-track knee arthroplasty -- status and future challenges.

Authors:  Henrik Kehlet; Emmanuel Thienpont
Journal:  Knee       Date:  2013-09       Impact factor: 2.199

4.  The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb.

Authors:  S S Jameson; A Bottle; A Malviya; S D Muller; M R Reed
Journal:  J Bone Joint Surg Br       Date:  2010-01

Review 5.  A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis.

Authors:  S Hu; Z-Y Zhang; Y-Q Hua; J Li; Z-D Cai
Journal:  J Bone Joint Surg Br       Date:  2009-07

6.  The necessity of pharmacological prophylaxis against venous thromboembolism in major joint arthroplasty.

Authors:  Mohamed Yassin; Chris Mitchell; Mohammed Diab; Colin Senior
Journal:  Int Orthop       Date:  2013-12-19       Impact factor: 3.075

7.  90-day mortality after 409,096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis.

Authors:  Linda P Hunt; Yoav Ben-Shlomo; Emma M Clark; Paul Dieppe; Andrew Judge; Alex J MacGregor; Jon H Tobias; Kelly Vernon; Ashley W Blom
Journal:  Lancet       Date:  2013-09-28       Impact factor: 79.321

8.  Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin.

Authors:  Clifford W Colwell; Mark I Froimson; Michael A Mont; Merrill A Ritter; Robert T Trousdale; Knute C Buehler; Andrew Spitzer; Thomas K Donaldson; Douglas E Padgett
Journal:  J Bone Joint Surg Am       Date:  2010-03       Impact factor: 5.284

9.  Low risk of thromboembolic complications after fast-track hip and knee arthroplasty.

Authors:  Henrik Husted; Kristian Stahl Otte; Billy B Kristensen; Thue Ørsnes; Christian Wong; Henrik Kehlet
Journal:  Acta Orthop       Date:  2010-10       Impact factor: 3.717

Review 10.  Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.

Authors:  Antonio Gómez-Outes; Ana Isabel Terleira-Fernández; M Luisa Suárez-Gea; Emilio Vargas-Castrillón
Journal:  BMJ       Date:  2012-06-14
View more
  1 in total

1.  Benefits of early ambulation within 24 h after total knee arthroplasty: a multicenter retrospective cohort study in China.

Authors:  Yi-Ting Lei; Jin-Wei Xie; Qiang Huang; Wei Huang; Fu-Xing Pei
Journal:  Mil Med Res       Date:  2021-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.